Latest News
Category: ASX
Telix has entered an exclusive commercial distribution agreement with Eckert & Ziegler for Telix’s prostate cancer imaging product Illuccix® for the German...
Read more
Telix provides the Chairman’s Address and the CEO’s Presentation to the Annual General Meeting of...
Read more
Telix announces global clinical supply agreement with Monrol for the supply of no carrier added lutetium-177 for use in Telix’s MTR...
Read more
Telix announces several key executive leadership appointments, including the establishment of an Asia-Pacific (APAC) operating region, further continuing the Company’s rapid commercial...
Read more
Telix announces it has completed a strategic manufacturing agreement with Global Medical Solutions to manufacture and supply finished unit doses of MTR products for clinical development...
Read more
Telix announces the Australian Therapeutic Goods Administration has accepted its prostate cancer imaging product submission and commenced the priority evaluation...
Read more
Telix Pharmaceuticals provides notice of The Annual General Meeting of Shareholders on Wednesday 12 May...
Read more
Telix announces it has completed an agreement with Grand River Aseptic Manufacturing to perform GMP manufacturing of Telix’s prostate cancer imaging...
Read more
Telix announces it has extended its non-exclusive global clinical and commercial supply agreements with Garching-based ITM...
Read more
Telix Pharmaceuticals Limited Releases Full-Year 2020 Results and 2020 Annual...
Read more